HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Carphology by Rajendra

The popularity of monoamine oxidase type B inhibitors (MAOIBs) in early Parkinson’s disease decreased after their use was found to be associated with increased mortality. But a recent meta-analysis of 17 randomised trials including 3525 patients showed no significant difference in mortality between patients taking MAOBIs and control patients. An accompanying editorial says these drugs clearly provide symptomatic benefit and probably entail no risk of increased mortality if they are used as monotherapy and in younger and otherwise healthy patients. As for their use in polytherapy and older people, the debate over mortality continues.

British Medical Journal, 2004, 329, 581–582.[Free Full Text]

MMR (mumps, measles and rubella) vaccination induces fever and predictably results in an increase in the rate of febrile seizures. A large and robust population based cohort study of over half a million children reported in JAMA confirms this. This increased rate of seizures was restricted to two weeks ...

[PDF of this article]